Skip to main content

Jeffrey B. Mirviss

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jeffrey B. Mirviss

Boston Scientific Corp reported in an 8-K filed September 4, 2025 that Jeffrey B. Mirviss retired as Executive Vice President and President, Peripheral Interventions, effective December 1, 2025. The proxy statement of Boston Scientific Corp reports total compensation of $4,159,959 for Jeffrey B. Mirviss in fiscal 2025, including a base salary of $702,042. Disclosed compensation is on record for 6 fiscal years.

“On August 29, 2025, Jeffrey B. Mirviss informed Boston Scientific Corporation (the "Company") that he has decided to retire from his role as Executive Vice President and President, Peripheral Interventions effective as of December 1, 2025.”
Boston Scientific Corp Form 8-K, filed September 4, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Boston Scientific Corp (BSX) $702,042 $4,159,959
2024 Boston Scientific Corp (BSX) $680,411 $4,027,076
2023 Boston Scientific Corp (BSX) $652,646 $3,782,995
2022 Boston Scientific Corp (BSX) $631,986 $3,562,244
2021 Boston Scientific Corp (BSX) $598,249 $3,456,145
2020 Boston Scientific Corp (BSX) $495,001 $2,956,196

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.